“…In this article we report an improved synthesis of CJ-16,264 [(+)- 1 ], which includes an enantioselective synthesis of the pyrrolizidine structural domain of the molecule (as opposed to its racemic form employed in our first synthesis). 2 In addition, herein we describe the design, synthesis, and biological evaluation of an array of racemic analogues [i.e., (±)- 2 –(±)- 6 , 7 , and (±)- 8 –(±)- 12 , Figure 2A] and a series of enantiopure analogues [i.e., (−)- 13 , (+)- 7 , (+)- 8 , and (−)- 14 –(+)- 20 , Figure 2B] for bioactivity comparison purposes. These investigations resulted in improvements of our original synthesis 2 and enabled the identification of a number of equipotent, or even more potent, and yet significantly less complex than the natural product, antibacterial agents.…”